Cargando…

Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study

AIMS/INTRODUCTION: To examine the incidence rate of severe non‐proliferative and proliferative diabetic retinopathy (severe‐NPDR/PDR) and determine its potential risk factors. MATERIALS AND METHODS: The study consisted of 1,169 participants (675 women) with type 2 diabetes mellitus, aged ≥20 years....

Descripción completa

Detalles Bibliográficos
Autores principales: Sardarinia, Mahsa, Asgari, Samaneh, Hizomi Arani, Reyhane, Eskandari, Fatemeh, Azizi, Fereidoun, Khalili, Davood, Hadaegh, Farzad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847124/
https://www.ncbi.nlm.nih.gov/pubmed/34403198
http://dx.doi.org/10.1111/jdi.13647
_version_ 1784651982829518848
author Sardarinia, Mahsa
Asgari, Samaneh
Hizomi Arani, Reyhane
Eskandari, Fatemeh
Azizi, Fereidoun
Khalili, Davood
Hadaegh, Farzad
author_facet Sardarinia, Mahsa
Asgari, Samaneh
Hizomi Arani, Reyhane
Eskandari, Fatemeh
Azizi, Fereidoun
Khalili, Davood
Hadaegh, Farzad
author_sort Sardarinia, Mahsa
collection PubMed
description AIMS/INTRODUCTION: To examine the incidence rate of severe non‐proliferative and proliferative diabetic retinopathy (severe‐NPDR/PDR) and determine its potential risk factors. MATERIALS AND METHODS: The study consisted of 1,169 participants (675 women) with type 2 diabetes mellitus, aged ≥20 years. A trained interviewer collected information about the history of pan‐retinal photocoagulation as a result of diabetic retinopathy. Multivariable Cox proportional hazards regression models were applied. RESULTS: We found 187 cases (126 women) of severe‐NPDR/PDR during a median follow‐up period of 12.7 years; the corresponding incidence rate was 13.6 per 1,000 person‐years. Being overweight (hazard ratio [HR], 95% confidence interval [CI] 0.60, 0.39–0.92) and obese (HR 0.48, 95% CI 0.27–0.83) were associated with lower risk, whereas being smoker (HR 1.75, 95% CI 1.12–2.74), having fasting plasma glucose levels 7.22–10.0 mmol/L (HR 2.81, 95% CI 1.70–4.62), fasting plasma glucose ≥10 mmol/L (HR 5.87, 95% CI 3.67–9.41), taking glucose‐lowering medications (HR 2.58, 95% CI 1.87–3.56), prehypertension status (HR 1.65, 95% CI 1.05–2.58) and newly diagnosed hypertension (HR 1.96, 95% CI 1.06–3.65) increased the risk of severe‐NPDR/PDR. Among newly diagnosed diabetes patients, being male was associated with a 59% lower risk of severe‐NPDR/PDR (HR 0.41, 95% CI 0.21–0.79). Furthermore, patients who had an intermediate level of education (6–12 years) had a higher risk of developing PDR (HR 1.86, 95% CI 1.05–3.30) compared with those who had <6 years of education. CONCLUSIONS: Among Iranians with type 2 diabetes mellitus, 1.36% developed severe‐NPDR/PDR annually. Normal bodyweight, being a smoker, out of target fasting plasma glucose level, prehypertension and newly diagnosed hypertension status were independent risk factors of severe‐NPDR/PDR. Regarding the sight‐threatening entity of advanced diabetic retinopathy, the multicomponent strategy to control diabetes, abstinence of smoking and tight control of blood pressure should be considered.
format Online
Article
Text
id pubmed-8847124
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-88471242022-02-25 Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study Sardarinia, Mahsa Asgari, Samaneh Hizomi Arani, Reyhane Eskandari, Fatemeh Azizi, Fereidoun Khalili, Davood Hadaegh, Farzad J Diabetes Investig Original Articles AIMS/INTRODUCTION: To examine the incidence rate of severe non‐proliferative and proliferative diabetic retinopathy (severe‐NPDR/PDR) and determine its potential risk factors. MATERIALS AND METHODS: The study consisted of 1,169 participants (675 women) with type 2 diabetes mellitus, aged ≥20 years. A trained interviewer collected information about the history of pan‐retinal photocoagulation as a result of diabetic retinopathy. Multivariable Cox proportional hazards regression models were applied. RESULTS: We found 187 cases (126 women) of severe‐NPDR/PDR during a median follow‐up period of 12.7 years; the corresponding incidence rate was 13.6 per 1,000 person‐years. Being overweight (hazard ratio [HR], 95% confidence interval [CI] 0.60, 0.39–0.92) and obese (HR 0.48, 95% CI 0.27–0.83) were associated with lower risk, whereas being smoker (HR 1.75, 95% CI 1.12–2.74), having fasting plasma glucose levels 7.22–10.0 mmol/L (HR 2.81, 95% CI 1.70–4.62), fasting plasma glucose ≥10 mmol/L (HR 5.87, 95% CI 3.67–9.41), taking glucose‐lowering medications (HR 2.58, 95% CI 1.87–3.56), prehypertension status (HR 1.65, 95% CI 1.05–2.58) and newly diagnosed hypertension (HR 1.96, 95% CI 1.06–3.65) increased the risk of severe‐NPDR/PDR. Among newly diagnosed diabetes patients, being male was associated with a 59% lower risk of severe‐NPDR/PDR (HR 0.41, 95% CI 0.21–0.79). Furthermore, patients who had an intermediate level of education (6–12 years) had a higher risk of developing PDR (HR 1.86, 95% CI 1.05–3.30) compared with those who had <6 years of education. CONCLUSIONS: Among Iranians with type 2 diabetes mellitus, 1.36% developed severe‐NPDR/PDR annually. Normal bodyweight, being a smoker, out of target fasting plasma glucose level, prehypertension and newly diagnosed hypertension status were independent risk factors of severe‐NPDR/PDR. Regarding the sight‐threatening entity of advanced diabetic retinopathy, the multicomponent strategy to control diabetes, abstinence of smoking and tight control of blood pressure should be considered. John Wiley and Sons Inc. 2021-09-13 2022-02 /pmc/articles/PMC8847124/ /pubmed/34403198 http://dx.doi.org/10.1111/jdi.13647 Text en © 2021 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Sardarinia, Mahsa
Asgari, Samaneh
Hizomi Arani, Reyhane
Eskandari, Fatemeh
Azizi, Fereidoun
Khalili, Davood
Hadaegh, Farzad
Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
title Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
title_full Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
title_fullStr Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
title_full_unstemmed Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
title_short Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
title_sort incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: more than a decade follow up in the tehran lipids and glucose study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847124/
https://www.ncbi.nlm.nih.gov/pubmed/34403198
http://dx.doi.org/10.1111/jdi.13647
work_keys_str_mv AT sardariniamahsa incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy
AT asgarisamaneh incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy
AT hizomiaranireyhane incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy
AT eskandarifatemeh incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy
AT azizifereidoun incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy
AT khalilidavood incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy
AT hadaeghfarzad incidenceandriskfactorsofseverenonproliferativeproliferativediabeticretinopathymorethanadecadefollowupinthetehranlipidsandglucosestudy